INVO Bioscience (INVO.US): The 2024 Q1 financial report achieved revenue of US$1,576 million, previous value of US$348.03 million; earnings per share were -0.42 USD, prior value of -4.00 USD.
INVO Bioscience(INVO.US)：2024年Q1财报实现营收157.6万美元，前值为34.803万美元；每股收益为-0.42美元，前值为-4.00美元。
INVO Bioscience (INVO.US): The 2024 Q1 financial report achieved revenue of US$1,576 million, previous value of US$348.03 million; earnings per share were -0.42 USD, prior value of -4.00 USD.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.